Risk of Herpes Zoster in Patients Receiving Anti-TNF-α in the Prospective French RATIO Registry

被引：36

作者：

Serac, Gaelle ^{[1
]}

Tubach, Florence ^{[2
]}

Mariette, Xavier ^{[3
]}

Salmon-Ceron, Dominique ^{[4
]}

Ravaud, Philippe ^{[5
]}

Liote, Frederic ^{[6
]}

Laharie, David ^{[7
]}

Ziza, Jean-Marc ^{[8
]}

Marguerie, Laurent ^{[9
]}

Bonnet, Christine ^{[10
]}

Falgarone, Geraldine ^{[11
]}

Nicolas, Nathalie ^{[2
]}

Lortholary, Olivier ^{[12
]}

Chosidow, Olivier ^{[13
]}

机构：

[1] Univ Paris 7 Diderot, Hop Bichat, AP HP, UFR Med,Serv Dermatol, Paris, France

[2] Univ Paris 07, Hop Bichat, AP HP,U738,INSERM CIE801, UFR Med,Dept Epidemiol,Biostat & Rech Clin,INSERM, Paris, France

[3] Univ Paris 11, Hop Bicetre, AP HP, INSERM,U1012,Serv Rhumatol, Le Kremlin Bicetre, France

[4] Univ Paris 05, Hop Cochin Broca Hotel Dieu, AP HP, Unite Malad Infect, Paris, France

[5] Univ Paris 05, Hop Cochin Broca Hotel Dieu, AP HP, Ctr Epidemiol Clin & Med Basee Preuves,INSERM,U73, Paris, France

[6] Univ Paris 07, Hop Lariboisiere, AP HP,UMR S606, UFR Med,Ctr Viggo Petersen,Serv Rhumatol,INSERM, Paris, France

[7] CHU Bordeaux, Hop Haut Leveque, Serv HepatoGastroenterol, Pessac, France

[8] Grp Hosp Diaconesses Croix St Simon, Serv Rhumatol, Paris, France

[9] Inst Calot Fdn Hopale, Serv Rhumatol, Berck Sur Mer, France

[10] Hop Dupuytren, Serv Rhumatol, Limoges, France

[11] Univ Paris 13, Hop Avicenne, AP HP, Serv Rhumatol,EA 4222 Li2p, Bobigny, France

[12] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,Serv Malad Infect & Trop,Ctr Infectiol Ne, Paris, France

[13] UPEC Univ Paris Est Creteil Val Marne, Hop Henri Mondor, AP HP, Serv Dermatol, Creteil, France

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2012年 / 132卷 / 03期

关键词：

NECROSIS-FACTOR-ALPHA; FACTOR MONOCLONAL-ANTIBODY; RHEUMATOID-ARTHRITIS; THERAPY; INFECTION; TUBERCULOSIS; ANTAGONISTS; TRANSPLANTATION; HOSPITALIZATION; ADALIMUMAB;

D O I：

10.1038/jid.2011.383

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：726 / 729

页数：4

共 14 条

[1] Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists [J].

Askling, Johan ;

Fored, C. Michael ;

Brandt, Lena ;

Baecklund, Eva ;

Bertilsson, Lennart ;

Feltelius, Nils ;

Coster, Lars ;

Geborek, Pierre ;

Jacobsson, Lennart T. ;

Lindblad, Staffan ;

Lysholm, Jorgen ;

Rantapaa-Dahlqvist, Solbritt ;

Saxne, Tore ;

van Vollenhoven, Ronald F. ;

Klareskog, Lars .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) :1339-1344

[2] Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies [J].

Dixon, W. G. ;

Symmons, D. P. M. ;

Lunt, M. ;

Watson, K. D. ;

Hyrich, K. L. ;

Silman, A. J. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2896-2904

[3] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].

FLYNN, JL ;

GOLDSTEIN, MM ;

CHAN, J ;

TRIEBOLD, KJ ;

PFEFFER, K ;

LOWENSTEIN, CJ ;

SCHREIBER, R ;

MAK, TW ;

BLOOM, BR .

IMMUNITY, 1995, 2 (06) :561-572

[4]

Furst DE, 2003, J RHEUMATOL, V30, P2563

[5] Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists [J].

Garcia-Doval, Ignacio ;

Perez-Zafrilla, Beatriz ;

Descalzo, Miguel Angel ;

Rosello, Rosa ;

Hernandez, Ma Victoria ;

Gomez-Reino, Juan J. ;

Carmona, Loreto .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) :1751-1755

[6] Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era [J].

Gourishankar, S ;

McDermid, JC ;

Jhangri, GS ;

Preiksaitis, JK .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) :108-115

[7] Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial [J].

Keystone, EC ;

Kavanaugh, AF ;

Sharp, JT ;

Tannenbaum, H ;

Hua, Y ;

Teoh, LS ;

Fischkoff, SA ;

Chartash, EK .

ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1400-1411

[8] Natural history of opportunistic disease in an HIV-infected urban clinical cohort [J].

Moore, RD ;

Chaisson, RE .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (07) :633-+

[9] Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry [J].

Salmon-Ceron, D. ;

Tubach, F. ;

Lortholary, O. ;

Chosidow, O. ;

Bretagne, S. ;

Nicolas, N. ;

Cuillerier, E. ;

Fautrel, B. ;

Michelet, C. ;

Morel, J. ;

Puechal, X. ;

Wendling, D. ;

Lemann, M. ;

Ravaud, P. ;

Mariette, X. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) :616-623

[10] Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir [J].

Steer, CB ;

Szer, J ;

Sasadeusz, J ;

Matthews, JP ;

Beresford, JA ;

Grigg, A .

BONE MARROW TRANSPLANTATION, 2000, 25 (06) :657-664

← 1 2 →